| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $786K | — | +1767.7% |
| Cost of Revenue | $744K | — | +3424.1% |
| Gross Profit | $3.6M | — | — |
| R&D Expense | $300 | — | -96.7% |
| SG&A Expense | $2.2M | — | -59.0% |
| Net Income | -$1.8M | — | +65.7% |
| EPS (Basic) | -$0.23 | — | -187.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $55K | +0.0% | +0.0% |
| Accounts Receivable | $730K | +709.8% | +2442.9% |
| Inventory | $757K | -20.3% | +123.2% |
| Current Assets | $6.5M | +8.4% | +62.5% |
| Total Assets | $38.4M | -6.3% | +341.5% |
| Current Liabilities | $5.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.9M | — | +58.0% |
| Investing Cash Flow | $392K | — | +207.9% |
| Financing Cash Flow | $5.0M | — | +0.0% |
| -44.4% |
| Total Liabilities | $5.1M | -14.6% | -44.7% |
| Stockholders' Equity | $33.3M | -4.9% | +6233.6% |